Overview of Reta

Reta represents the cutting edge of incretin research — a triple-receptor agonist that simultaneously activates GIP, GLP-1, AND glucagon receptors. This novel mechanism combines the incretin effects of GLP-1/GIP (which Tirzepatide already targets) with the energy expenditure effects of glucagon receptor activation, creating a uniquely comprehensive metabolic research tool.

Each vial available from SteroidsCanada.ca contains 10mg of lyophilized Reta, manufactured to rigorous pharmaceutical-grade standards and independently verified for purity exceeding 98% via HPLC analysis. This makes it an ideal choice for qualified researchers and laboratory professionals seeking dependable, high-quality peptides for triple receptor agonist research applications.

Mechanism of Action

The unique addition of glucagon receptor agonism differentiates Reta from all previous metabolic peptides. While GLP-1 and GIP work on the ‘input’ side (insulin secretion, appetite suppression), glucagon agonism adds ‘output’ effects — increasing energy expenditure, hepatic lipolysis, and fat oxidation. This three-pronged approach is driving significant research interest in advanced metabolic pathway studies.

Key Research Applications

Product Specifications

Reconstitution Guidelines

Reta is supplied as a lyophilized (freeze-dried) powder that must be reconstituted with sterile bacteriostatic water (0.9% benzyl alcohol) before use in research applications. The recommended reconstitution volume for this vial is 2mL of bacteriostatic water, which yields a concentration suitable for precise research dosing.

Reconstitution Math — Quick Reference

If you add 2mL of bacteriostatic water to this 10mg vial:

On a standard 100 IU insulin syringe, here’s what each measurement equals for research reference:

Reconstitution Best Practices

• Use sterile bacteriostatic water (0.9% benzyl alcohol preservative)
• Add diluent slowly along the vial wall — never directly onto the peptide cake
• Gently swirl to dissolve — never shake the vial vigorously
• Allow the peptide to fully dissolve before drawing any dose
• Store reconstituted vials at 2–8°C (refrigerator)
• Use reconstituted peptide within 28–60 days depending on specific research requirements
• Always use sterile technique when drawing from the reconstituted vial

Research Protocol Guidelines

Research protocols start very conservatively (0.5-1mg weekly equivalent) due to the novel triple-agonism mechanism.

Typical Research Timeline

• Week 1-4: Conservative titration — novel pathway adaptation
• Week 5-12: Progressive research dose escalation
• Week 13-20: Extended research protocol phase
• Week 21-24: Long-duration triple-agonist research

Individual research results vary based on protocol design, specific research objectives, and research model characteristics. The above timeline represents commonly observed patterns in published research literature.

Research Stacking Protocols

In research applications, Reta is often studied in combination with complementary research peptides to investigate pathway interactions. Common research combinations include:

• Reta alone: Pure triple-agonist research
• Reta + BPC-157: Metabolic + GI research
• Reta vs Tirzepatide: Comparative mechanism studies

Any research stacking protocol should be designed based on specific investigative objectives and informed by current scientific literature.

Why Choose SteroidsCanada.ca?

• ✅ Pharmaceutical-grade Reta — lab tested for purity and potency
• ✅ Discreet shipping across Canada — plain outer packaging always
• ✅ Proper cold-chain handling to preserve peptide integrity
• ✅ Same-day dispatch on orders placed before 2PM EST
• ✅ COA available on request for every batch and SKU
• ✅ Secure payment — Interac E-Transfer and cryptocurrency
• ✅ Free shipping on all orders over $600 CAD
• ✅ Competitive Canadian pricing with no hidden fees
• ✅ Responsive customer service and reliable restocking